metformin has been researched along with Poisoning, Lead in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Metformin has both hypoglycaemic effects and reno-protection ability." | 1.48 | Metabolic profiling of metformin treatment for low-level Pb-induced nephrotoxicity in rat urine. ( Chen, SM; Huang, YS; Lee, JA; Wang, SH, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, YS | 1 |
| Wang, SH | 1 |
| Chen, SM | 1 |
| Lee, JA | 1 |
1 other study available for metformin and Poisoning, Lead
| Article | Year |
|---|---|
Metabolic profiling of metformin treatment for low-level Pb-induced nephrotoxicity in rat urine.
Topics: Administration, Oral; Animals; Biological Factors; Disease Models, Animal; Environmental Pollutants; | 2018 |